Disturbed lipid metabolism in glycogen storage disease type 1

The Metabolic Basis of Inherited Disease.

(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807 · see citing works

The Mitochondrial Carnitine Palmitoyltransferase System — From Concept to Molecular Analysis

McGarry, J. D., & Brown, N. F. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00001.x · Cited by 1,616 · see citing works

Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes

Shimomura, I., Bashmakov, Y. K., Ikemoto, S., Horton, J. D., Brown, M. S., & Goldstein, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13656 · Cited by 779 · see citing works

Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes

Foretz, M., Guichard, C., Ferré, P., & Foufelle, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12737 · Cited by 748 · see citing works

Sterol regulatory element-binding proteins

Morton, J. D., & Shimomura, L. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199904000-00008 · Cited by 324 · see citing works

Effects of Acute Hyperinsulinemia on VLDL Triglyceride and VLDL ApoB Production in Normal Weight and Obese Individuals

Lewis, G. F., Uffelman, K. D., Szeto, L., & Steiner, G. A. (1993) · Diabetes · doi:10.2337/diab.42.6.833 · Cited by 323 · see citing works

Cornstarch Therapy in Type I Glycogen-Storage Disease

Chen, Y.-T., Cornblath, M., & Sidbury, J. B. (1984) · New England Journal of Medicine · doi:10.1056/nejm198401193100306 · Cited by 316 · see citing works

Mass isotopomer distribution analysis: a technique for measuring biosynthesis and turnover of polymers

Hellerstein, M. K., & Neese, R. A. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.263.5.e988 · Cited by 284 · see citing works

Glycogen Storage Disease in Adults

Talente, G. M., Coleman, R. A., Alter, C., Baker, L., Brown, B. I., Cannon, R. A., Chen, Y.-T., Crigler, J. F., Ferreira, P., Haworth, J. C., et al. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-3-199402010-00008 · Cited by 250 · see citing works

Continuous Nocturnal Intragastric Feeding for Management of Type 1 Glycogen-Storage Disease

Greene, H. L., Slonim, A. E., O’Neill, J. A., & Burr, I. M. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602192940805 · Cited by 229 · see citing works

Sequence of a putative glucose 6‐phosphate translocase, mutated in glycogen storage disease type Ib 1

Gerin, I., Veiga‐da‐Cunha, M., Achouri, Y., Collet, J., & SCHAFTINGEN, E. V. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01463-4 · Cited by 212 · see citing works

Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects.

Malmström, R., Packard, C. J., CASLAKE, M. J., Bedford, D. K., Stewart, P., Yki‐Järvinen, H., Shepherd, J., & Taskinen, M. (1998) · Diabetes · doi:10.2337/diabetes.47.5.779 · Cited by 197 · see citing works

Glucose stimulation of lipogenic enzyme gene expression in cultured white adipose tissue. A role for glucose 6-phosphate.

Foufelle, F., Gouhot, B., Pégorier, J. P., Perdereau, D., Girard, J. R., & Ferré, P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36717-1 · Cited by 186 · see citing works

Glucose-6-phosphatase deficiency glycogen storage disease. Studies on the interrelationships of carbohydrate, lipid, and purine abnormalities.

Howell, R. R., Ashton, D. M., & Wyngaarden, J. Β. (1962) · PubMed · Cited by 186 · see citing works

Coordinated regulation of hormone-sensitive lipase and lipoprotein lipase in human adipose tissue in vivo: Implications for the control of fat storage and fat mobilization

Frayn, K. N., Coppack, S. W., Fielding, B. A., & Humphreys, S. M. (1995) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(94)00011-q · Cited by 175 · see citing works

GLUCOSE-6-PHOSPHATASE DEFICIENCY GLYCOGEN STORAGE DISEASE

Howell, R. R., Ashton, D. M., & Wyngaarden, J. Β. (1962) · PEDIATRICS · doi:10.1542/peds.29.4.553 · Cited by 173 · see citing works

The glucose-6 phosphatase gene is expressed in human and rat small intestine: Regulation of expression in fasted and diabetic rats

Rajas, F., Bruni, N., Montano, S., Zitoun, C., & Mithieux, G. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70559-7 · Cited by 171 · see citing works

Glucose and Insulin Function through Two Distinct Transcription Factors to Stimulate Expression of Lipogenic Enzyme Genes in Liver

Koo, S., Stoeckman, A. K., & Towle, H. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010029200 · Cited by 160 · see citing works

GLYCOGEN STORAGE DISEASE

(1952) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1952.tb84070.x · Cited by 152 · see citing works

Isolation of the gene for murine glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1A.

Shelly, L. L., Lei, K. J., Pan, C. J., Sakata, S., Ruppert, S., Schütz, G., & CHOU, J. Y. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80563-8 · Cited by 144 · see citing works

Transcriptional Glucose Signaling through The Glucose Response Element Is Mediated by the Pentose Phosphate Pathway

Doiron, B., Cuif, M., Chen, R., & Kahn, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5321 · Cited by 142 · see citing works

Glycogen storage disease, types I to XCriteria for morphologic diagnosis

McAdams, A. J., Hug, G., & BOVE, K. (1974) · Human Pathology · doi:10.1016/s0046-8177(74)80024-9 · Cited by 111 · see citing works

The Glycogen Storage Diseases

Fernandes, J. (1990) · Springer eBooks · doi:10.1007/978-3-662-02613-7_7 · Cited by 90 · see citing works

Glucose Regulation of the Acetyl-CoA Carboxylase Promoter PI in Rat Hepatocytes

O’Callaghan, B. L., Koo, S., Wu, Y., Freake, H. C., & Towle, H. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101557200 · Cited by 85 · see citing works

Induction of fatty acid synthase and S14 gene expression by glucose, xylitol and dihydroxyacetone in cultured rat hepatocytes is closely correlated with glucose 6-phosphate concentrations

MOURRIERAS, F., Foufelle, F., Foretz, M., MORIN, J., Bouché, S., & Ferré, P. (1997) · Biochemical Journal · doi:10.1042/bj3260345 · Cited by 83 · see citing works

Circulating lipids and lipoproteins in glycogen storage disease type I with nocturnal intragastric feeding.

Levy, E. H., Thibault, L., ROY, C. C., Bendayan, M., Lepage, G., & Letarte, J. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38543-6 · Cited by 78 · see citing works

Acute Inhibition of Glucose-6-Phosphate Translocator Activity Leads to Increased De Novo Lipogenesis and Development of Hepatic Steatosis Without Affecting VLDL Production in Rats

Bandsma, R., Wiegman, C., Herling, A. W., Burger, H.-J., ter Harmsel, A., Meijer, A. J., Romijn, J. A., Reijngoud, D., & Kuipers, F. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2591 · Cited by 70 · see citing works

The long-term outcome of patients with glycogen storage disease type Ia

Smit, G. (1993) · European Journal of Pediatrics · doi:10.1007/bf02072089 · Cited by 69 · see citing works

Coordinate Regulation of Lipogenesis, the Assembly and Secretion of Apolipoprotein B-containing Lipoproteins by Sterol Response Element Binding Protein 1

Wang, S.-L., Du, E. Z., Martin, T. D., & Davis, R. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19351 · Cited by 66 · see citing works

Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects

Watts, G. F., Naoumova, R. P., Cummings, M. H., Umpleby, A. M., Slavin, B. M., Sönksen, P. H., & Thompson, G. R. (1995) · Metabolism · doi:10.1016/0026-0495(95)90104-3 · Cited by 58 · see citing works

Hyperlipemia in Children with Liver Glycogen Disease

Fernandes, J., & Pikaar, N. A. (1969) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/22.5.617 · Cited by 51 · see citing works

Hyperlipidemia and fatty acid composition in patients treated for type IA glycogen storage disease

Greene, H. L., Swift, L. L., & Knapp, H. R. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82052-9 · Cited by 47 · see citing works

Increased lipogenesis and resistance of lipoproteins to oxidative modification in two patients with glycogen storage disease type 1a

Bandsma, R., Rake, J. P., Visser, G., Neese, R. A., Hellerstein, M. K., van Duyvenvoorde, W., Princen, H. M. G., Stellaard, F., Smit, G., & Kuipers, F. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.121382 · Cited by 46 · see citing works

Triglyceride Clearing in Glycogen Storage Disease

Forget, P., Fernandes, J., & Begemann, P. H. (1974) · Pediatric Research · doi:10.1203/00006450-197402000-00008 · Cited by 45 · see citing works

Gastric Drip Feeding in Patients with Glycogen Storage Disease Type I: Its Effects on Growth and Plasma Lipids and Apolipoproteins

Fernandes, J., Alaupovic, P., & Wit, J. M. (1989) · Pediatric Research · doi:10.1203/00006450-198904000-00002 · Cited by 35 · see citing works

The hyperlipidemia in glycogen storage disease.

Jakovcic, S., Khachadurian, A. K., & Hsia, D. Y. (1966) · PubMed · Cited by 34 · see citing works

Decreased ketogenesis in von Gierke's disease (Type I glycogenosis)

Binkiewicz, A., & Senior, B. (1973) · The Journal of Pediatrics · doi:10.1016/s0022-3476(73)80531-1 · Cited by 33 · see citing works

Genomic structure of the human glucose 6-phosphate translocase gene and novel mutations in the gene of a Japanese patient with glycogen storage disease type Ib

Ihara, K., Kuromaru, R., & Hara, T. (1998) · Human Genetics · doi:10.1007/s004390050856 · Cited by 33 · see citing works

Splanchnic metabolism in von Gierke's disease (glycogenosis type I).

Havel, R. J., BALASSE, E. O., Williams, H. E., Jp, K., & Segel, N. (1969) · PubMed · Cited by 31 · see citing works

Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type l

Levy, E. H., Thibault, L., Turgeon, J. P., ROY, C. C., Gurbindo, C., Lepage, G., Godard, M., Rivard, G., & Seidman, E. G. (1993) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/57.6.922 · Cited by 29 · see citing works

Glucose Phosphorylation Is Essential for the Turnover of Neutral Lipid and the Second Stage Assembly of Triacylglycerol-Rich ApoB-Containing Lipoproteins in Primary Hepatocyte Cultures

Brown, A.-M., Wiggins, D. K., & Gibbons, G. F. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.2.321 · Cited by 26 · see citing works

Mechanisms of hypercholesterolaemia in glycogen storage disease type I: defective metabolism of low density lipoprotein in cultured skin fibroblasts

Levy, E. H., Thibault, L., ROY, C. C., Letarte, J., Lambert, M. A., & Seidman, E. G. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb01852.x · Cited by 23 · see citing works

Study of Liver Metabolism in Glucose-6-Phosphatase Deficiency (Glycogen Storage Disease Type 1A) by P-31 Magnetic Resonance Spectroscopy

Oberhaensli, R. D., Rajagopalan, B., Taylor, D. J. F., Radda, G. K., Je, C., & Leonard, J. V. (1988) · Pediatric Research · doi:10.1203/00006450-198804000-00007 · Cited by 22 · see citing works

Plasma and lipoprotein fatty acid composition in glycogen storage disease type I

Levy, E. H., Letarte, J., Lepage, G., Thibault, L., & ROY, C. C. (1987) · Lipids · doi:10.1007/bf02537265 · Cited by 19 · see citing works

Direct association between the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 and plasma mevalonic acid and lathosterol concentrations in man

Riches, F. M., Watts, G. F., Naoumova, R. P., Kelly, J. M., Croft, K. D., & Thompson, G. R. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00153-6 · Cited by 18 · see citing works

Glycogen storage disease: long‐term follow‐up of nocturnal intragastric feeding

Michels, V. V., Beaudet, A. L., Potts, V. E., & Montandon, C. M. (1982) · Clinical Genetics · doi:10.1111/j.1399-0004.1982.tb00750.x · Cited by 10 · see citing works

Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline

Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887 · see citing works

Sugar, Uric Acid, and the Etiology of Diabetes and Obesity

Johnson, R. J., Nakagawa, T., Sánchez‐Lozada, L. G., Shafiu, M., Sundaram, S. S., Le, M. T., Ishimoto, T., Sautin, Y. Y., & Lanaspa, M. A. (2013) · Diabetes · doi:10.2337/db12-1814 · Cited by 773 · see citing works

Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I)

Rake, J. P., Visser, G., Labrune, P., Leonard, J. V., Ullrich, K., & Smit, P. (2002) · European Journal of Pediatrics · doi:10.1007/s00431-002-0999-4 · Cited by 423 · see citing works

Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance

Stanhope, K. L., & Havel, P. J. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282f2b24a · Cited by 272 · see citing works

Glucose-6-phosphatase deficiency

Froissart, R., Piraud, M., Mollet-Boudjemline, A., Vianey‐Saban, C., Petit, F. M., Hubert-Buron, A., Eberschweiler, P. T., Gajdos, V., & Labrune, P. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-27 · Cited by 264 · see citing works

Plasma palmitoleic acid content and obesity in children

Okada, T., Furuhashi, N., Kuromori, Y., Miyashita, M., Iwata, F., & Harada, K. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.4.747 · Cited by 163 · see citing works

Natural History of Hepatocellular Adenoma Formation in Glycogen Storage Disease Type I

Wang, D. Q., Fiske, L. M., Carreras, C. M., & Weinstein, D. A. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.02.031 · Cited by 119 · see citing works

Nutritional Therapy for Glycogen Storage Diseases

Heller, S., Worona-Dibner, L., & Consuelo, A. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181818ea5 · Cited by 73 · see citing works

Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context

Monteillet, L., Gjorgjieva, M., Silva, M., Verzieux, V., Imikirene, L., Duchampt, A., Guillou, H., Mithieux, G., & Rajas, F. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.07.006 · Cited by 64 · see citing works

Insights into the Pathogenesis and Treatment of Cancer from Inborn Errors of Metabolism

Erez, A., Shchelochkov, O. A., Plon, S. E., Scaglia, F., & Lee, B. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.03.005 · Cited by 65 · see citing works

Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa)

Farah, B. L., Sinha, R. A., Wu, Y., Singh, B. K., Lim, A. R., Hirayama, M., Landau, D. J., Bay, B., Koeberl, D. D., & Yen, P. M. (2017) · Scientific Reports · doi:10.1038/srep44408 · Cited by 57 · see citing works

Approach to hypoglycemia in infants and children

Gandhi, K. K. (2017) · Translational Pediatrics · doi:10.21037/tp.2017.10.05 · Cited by 58 · see citing works

The Glycogen Storage Diseases and Related Disorders

Smit, G., Rake, J. P., Akman, H. O., & DiMauro, S. (2006) · Springer eBooks · doi:10.1007/978-3-540-28785-8_6 · Cited by 53 · see citing works

Regulation of Liver Metabolism by the Endosomal GTPase Rab5

Zeigerer, A., Bogorad, R. L., Sharma, K., Gilleron, J., Seifert, S., Sales, S., Berndt, N., Bulik, S., Marsico, G., D’Souza, R. C. J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.018 · Cited by 52 · see citing works

Insulin‐resistance in glycogen storage disease type Ia: linking carbohydrates and mitochondria?

Rossi, A., Ruoppolo, M., Formisano, P., Villani, G. R. D., Albano, L., Gallo, G., Crisci, D., Moccia, A., Parenti, G., Strisciuglio, P., et al. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-018-0149-4 · Cited by 47 · see citing works

Increased Prevalence of Thyroid Autoimmunity and Hypothyroidism in Patients with Glycogen Storage Disease Type I

Melis, D., Pivonello, R., Parenti, G., Casa, R. D., Salerno, M., Lombardi, G., Sebastio, G., Colao, A., & Andria, G. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.11.056 · Cited by 44 · see citing works

Treatment options for hypertriglyceridemia: From risk reduction to pancreatitis

Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., & Stalenhoef, A. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.002 · Cited by 50 · see citing works

Glycogen storage disease type I: clinical and laboratory profile

dos Santos, B. L., de Souza, C. F. M., Schüler‐Faccini, L., Refosco, L. F., Epifânio, M., Nalin, T., Vieira, S. M. G., & Schwartz, I. V. D. (2014) · Jornal de Pediatria · doi:10.1016/j.jped.2014.02.005 · Cited by 37 · see citing works

Metabolic characterisation of plasma in juveniles with glycogen storage disease type 1a (GSD1a) by high‐resolution 1 H NMR spectroscopy

Duarte, I. F., Goodfellow, B. J., Barros, A. S., Jones, J. G., Barosa, C., Diogo, L. M., Garcia, P., & Gil, A. M. (2006) · NMR in Biomedicine · doi:10.1002/nbm.1073 · Cited by 34 · see citing works

Creatine: A valuable supplement in aquafeeds?

Wuertz, S., & Reiser, S. (2022) · Reviews in Aquaculture · doi:10.1111/raq.12717 · Cited by 31 · see citing works

Imbalanced cortisol concentrations in glycogen storage disease type I: evidence for a possible link between endocrine regulation and metabolic derangement

Rossi, A., Simeoli, C., Salerno, M., Ferrigno, R., Casa, R. D., Colao, A. A. L., Strisciuglio, P., Parenti, G., Pivonello, R., & Melis, D. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01377-w · Cited by 31 · see citing works

Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk

Nagasaka, H., Hirano, K., Ohtake, A., Miida, T., Takatani, T., Murayama, K., Yorifuji, T., Kobayashi, K., Kanazawa, M., Ogawa, A., et al. (2007) · European Journal of Pediatrics · doi:10.1007/s00431-006-0372-0 · Cited by 30 · see citing works

Hepatic stress associated with pathologies characterized by disturbed glucose production

Gjorgjieva, M., Mithieux, G., & Rajas, F. (2019) · Cell Stress · doi:10.15698/cst2019.03.179 · Cited by 30 · see citing works

Chubby Face and the Biochemical Parameters for the Early Diagnosis of Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency

Chen, H., Chen, H., Ni, Y., Lee, N., Chien, Y., Hwu, W., Huang, Y., Chiu, P., & Chang, M. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318162d96d · Cited by 25 · see citing works

Systems biology from micro-organisms to human metabolic diseases: the role of detailed kinetic models

Bakker, B. M., van Eunen, K., Jeneson, J. A. L., van Riel, N. A. W., Bruggeman, F. J., & Teusink, B. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381294 · Cited by 24 · see citing works

Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia

Hijmans, B. S., Boss, A., van Dijk, T. H., Soty, M., Wolters, H., Mutel, E., Groen, A. K., Derks, T. G. J., Mithieux, G., Heerschap, A., et al. (2017) · Hepatology · doi:10.1002/hep.29389 · Cited by 24 · see citing works

Untargeted plasma metabolomics identifies broad metabolic perturbations in glycogen storage disease type I

Mathis, T., Poms, M., Köfeler, H. C., Gautschi, M., Plecko, B., Baumgartner, M. R., & Hochuli, M. (2021) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12451 · Cited by 22 · see citing works

Glycogen at the Crossroad of Stress Resistance, Energy Maintenance, and Pathophysiology of Aging

Gusarov, I., & Nudler, E. (2018) · BioEssays · doi:10.1002/bies.201800033 · Cited by 23 · see citing works

Glycogen Storage Disease type 1a – a secondary cause for hyperlipidemia: report of five cases

Carvalho, P. M. S., Silva, N. J. M. M., Dias, P., Porto, J. F. C., Santos, L. C., & Costa, N. (2013) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-12-25 · Cited by 21 · see citing works

Causative and Sanative dynamicity of ChREBP in Hepato-Metabolic disorders

Daniel, P. V., & Mondal, P. (2020) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2020.151128 · Cited by 18 · see citing works

Hepatic anaplerotic outflow fluxes are redirected from gluconeogenesis to lactate synthesis in patients with Type 1a glycogen storage disease

Jones, J. G., Garcia, P., Barosa, C., Delgado, T. C., & Diogo, L. M. (2009) · Metabolic Engineering · doi:10.1016/j.ymben.2009.01.003 · Cited by 18 · see citing works

CD30+ anaplastic large cell lymphoma complicated by pyoderma gangrenosum with increased levels of serum cytokines

Saito, S., Yasui, K., Hosoda, W., Ogawa, M., Kobayashi, N., Sakashita, K., & Koike, K. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2006.00697.x · Cited by 18 · see citing works

Mechanisms by Which Metabolic Reprogramming in GSD1 Liver Generates a Favorable Tumorigenic Environment

Gjorgjieva, M., Oosterveer, M. H., Mithieux, G., & Rajas, F. (2016) · Journal of Inborn Errors of Metabolism and Screening · doi:10.1177/2326409816679429 · Cited by 17 · see citing works

Multiple voxel 1H MR spectroscopy of phosphorylase-b kinase deficient patients (GSD IXa) showing an accumulation of fat in the liver that resolves with aging

Sijens, P. E., Smit, G., Borgdorff, M. A. J., Kappert, P., & Oudkerk, M. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.06.021 · Cited by 16 · see citing works

Hypoglycemia in the toddler and child

Langdon, D. R., Stanley, C. A., & Sperling, M. A. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00030-5 · Cited by 14 · see citing works

Intestinal Glucose-dependent Expression of Glucose-6-phosphatase

Carrière, V., Gall, M. L., Gouyon-Saumande, F., Schmoll, D., Brot‐Laroche, E., Chauffeton, V., Chambaz, J., & Rousset, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502192200 · Cited by 14 · see citing works

Disturbed sphingolipid metabolism with elevated 1-deoxysphingolipids in glycogen storage disease type I – A link to metabolic control

Hornemann, T., Alecu, I., Hagenbuch, N., Zhakupova, A., Cremonesi, A., Gautschi, M., Jung, H. H., Meienberg, F., Bilz, S., Christ, E., et al. (2018) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.07.003 · Cited by 12 · see citing works

Acute pancreatitis in a patient with glycogen storage disease type 1a

Hirashima, K., Kido, J., Matsumoto, S., & Nakamura, K. (2019) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2019.01.009 · Cited by 10 · see citing works

Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia

Rossi, A., Assunto, A., Rosano, C. L., Tucci, S., Ruoppolo, M., Caterino, M., Pirozzi, F., Strisciuglio, P., Parenti, G., & Melis, D. (2023) · Genes & Nutrition · doi:10.1186/s12263-023-00729-y · Cited by 10 · see citing works

Trans-ancestral rare variant association study with machine learning-based phenotyping for metabolic dysfunction-associated steatotic liver disease

Chen, R. K., Petrazzini, B. O., Duffy, Á., Rocheleau, G., Jordan, D. M., Bansal, M. B., & Do, R. (2025) · Genome biology · doi:10.1186/s13059-025-03518-5 · Cited by 8 · see citing works

Glycogen storage disease type I: clinical and laboratory profile

dos Santos, B. L., de Souza, C. F. M., Schüler‐Faccini, L., Refosco, L. F., Epifânio, M., Nalin, T., Vieira, S. M. G., & Schwartz, I. V. D. (2014) · Jornal de Pediatria (Versão em Português) · doi:10.1016/j.jpedp.2014.08.002 · Cited by 8 · see citing works

Gum Guar fiber associated with fructose reduces serum triacylglycerol but did not improve the glucose tolerance in rats

Motoyama, C. S. D. M., Pinto, M. J., Lira, F. S., Ribeiro, E. B., Nascimento, C. M., & Oyama, L. M. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-61 · Cited by 8 · see citing works

Renal Disease in Type I Glycogen Storage Disease

CHOU, J. Y., Mansfield, B. C., & Weinstein, D. A. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-449851-8.00041-3 · Cited by 7 · see citing works

Liver transcriptomic changes associated with ritonavir-induced hyperlipidemia in sensitive and resistant strains of rats

Yang, Y., Dahly-Vernon, A. J., Blomme, E. A. G., Lai‐Zhang, J., Kempf, D. J., Marsh, K. C., Harrington, Y. A., Nye, S. H., Evans, D. L., Roman, R. J., et al. (2010) · The Veterinary Journal · doi:10.1016/j.tvjl.2010.04.017 · Cited by 7 · see citing works

Hepatocyte specific expression of an oncogenic variant of β-catenin results in lethal metabolic dysfunction in mice

Lemberger, U. J., Fuchs, C. D., Schöfer, C., Bileck, A., Gerner, C., Stojaković, T., Taketo, M. M., Trauner, M. A., Egger, G., & Österreicher, C. H. (2018) · Oncotarget · doi:10.18632/oncotarget.24346 · Cited by 7 · see citing works

A specific serum lipid signature characterizes patients with glycogen storage disease type Ia

Rossi, A., Ruoppolo, M., Fedele, R., Pirozzi, F., Rosano, C. L., Auricchio, R., Melis, D., Strisciuglio, P., Oosterveer, M. H., Derks, T. G. J., et al. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100651 · Cited by 6 · see citing works

Hypoglycemia in the Toddler and Child

Wolfsdorf, J. I., & Stanley, C. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00023-3 · Cited by 5 · see citing works

SGLT2 inhibition alleviated hyperglycemia, glucose intolerance, and dumping syndrome-like symptoms in a patient with glycogen storage disease type Ia: a case report

Katayama, D., Baba, H., Kuwabara, T., Kido, J., Mitsubuchi, H., Matsumoto, S., & Nakamura, K. (2021) · Journal of Medical Case Reports · doi:10.1186/s13256-020-02658-5 · Cited by 4 · see citing works

Glikojen depo tip 1a ve tip 1b olgularında klinik özellikler ve hastalığın seyri

Eminoğlu, F. T., Tümer, L., Okur, İ., Ezgü, F. S., & Hasanoğlu, A. (2013) · Türk Pediatri Arşivi · doi:10.4274/tpa.185 · Cited by 4 · see citing works

Glycogen Storage Disease Type III with Hypoketosis

Clemente, M., Gussinyer, M., Arranz, J. A., Riudor, E., Yeste, D., Albisu, M., & Carrascosa, A. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.134 · Cited by 3 · see citing works

Does increased fatty acid oxidation enhance development of liver cirrhosis and progression to hepatocellular carcinoma in patients with glycogen storage disease type-III?

Herrema, H., Smit, G., Reijngoud, D., & Kuipers, F. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.05.007 · Cited by 3 · see citing works

Enfermedades metabólicas hereditarias

Cortizo, A. M. (2021) · doi:10.35537/10915/115948 · Cited by 2 · see citing works

Medium-Chain Triglyceride Oil and Dietary Intervention Improved Body Composition and Metabolic Parameters in Children with Glycogen Storage Disease Type 1 in Jordan: A Clinical Trial

Subih, H. S., Qudah, R. A., Janakat, S., Rimawi, H., Elsahoryi, N. A., & Alyahya, L. (2024) · Foods · doi:10.3390/foods13071091 · Cited by 2 · see citing works

Other Inherited Metabolic Disorders of the Liver

Leonis, M. A., & Balistreri, W. F. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00076-7 · Cited by 2 · see citing works

Glicogenose Tipo I (Doença de Von Gierke): Relato de Dois Casos com Grave Dislipidemia

Ballavenuto, J. M. A., de Oliveira, J. D. ́. D., & Alves, R. J. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20190037 · Cited by 2 · see citing works

Morphofunctional Assessment beyond Malnutrition: Fat Mass Assessment in Adult Patients with Phenylketonuria—Systematic Review

Pérez, L. M. L., Fernández-Bueso, M., Guzmán-Carmona, C., López-Navia, A., & García-Lobato, C. (2024) · Nutrients · doi:10.3390/nu16121833 · Cited by 2 · see citing works

Glycogen storage disease type Ia complicated by gestational hypertriglyceridemic pancreatitis: A rare case report

Zhang, Y., Cui, L., Gao, J., Song, Y., Fan, Y., & Yang, M. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-08067-0 · Cited by 1 · see citing works

Infantile extreme hypertriglyceridemia diagnosed as glycogen storage disease type Ia: A case report

Yuan, C., Liu, Y., Lyu, J., Sun, X., & Wu, J. K. (2026) · Medicine · doi:10.1097/md.0000000000047959 · Cited by 1 · see citing works

Master role of glucose-6-phosphate in cell signaling and consequences of its deregulation in the liver and kidneys

Rajas, F., & Mithieux, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-849886-6.00021-5 · Cited by 1 · see citing works

Increased atherosclerosis in a mouse model of glycogen storage disease type 1a

Rose, A. M. L., Groenen, A. G., Halmos, B., Bazioti, V., Rutten, M. G. S., Krishnamurthy, K. A., Koster, M. H., Kloosterhuis, N., Smit, M., Havinga, R., et al. (2022) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2022.100872 · Cited by 1 · see citing works

Transcriptional Regulation of the Human Hepatic Lipase Gene

Sijbrands, E. J. G., Verhoeven, A. J. M., & van Deursen, D. (2005) · Cited by 1 · see citing works

Untargeted plasma metabolomics identifies broad metabolic perturbations in glycogen storage disease type I

Mathis, T., Poms, M., Gautschi, M., Barbara, P., Matthias, B., & Hochuli, M. (2020) · Endocrine Abstracts · doi:10.1530/endoabs.70.aep309 · Cited by 1 · see citing works

Glicogenose Tipo I Disfunção do Complexo Glicose-6-fosfátase

Santos‐Antunes, J., & Fontes, R. (2009) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

Glycogen storage disease type I: clinical, biochemical and genetic aspects, and implications for treatment and follow-up (management of glycogen storage disease type I)

Rake, J. P. (2003) · University of Groningen research database (University of Groningen / Centre for Information Technology)

Liver-specific overexpression of the IGF2 mRNA binding protein p62 induces a fatty liver disease phenotype

Tybl, E. (2009) · Publications of the UdS (Saarland University) · doi:10.22028/d291-22660

Does increased fatty acid oxidation enhance development of liver cirrhosis and progression to hepatocellular carcinoma in patients with glycogen storage disease type-III?

Jc, G., Salgado, F. D. A., Phytotherapy, P. D., & Jiménez‐Sáenz, M. (2007)

Lipid profile of children with glycogen storage disease

Строкова, Т. В., Pavlovskaya, E. V., Zubovich, A. I., Varaeva, Y. R., Polenova, N., Livansova, E. N., Bagaeva, M. E., Сурков, А. Г., Kosyura, S. D., & Starodubova, A. V. (2019) · Vessel Plus · doi:10.20517/2574-1209.2019.08

General Discussion and Future Perspectives

Cassarini, C. (2019) · CRC Press eBooks · doi:10.1201/9780429448300-7

Role of hepatic glucose signaling in the development of liver disease

Yu, L. (2020) · doi:10.33612/diss.126530476

Novel monitoring and management strategies for hepatic glycogen storage diseases

Rossi, A. (2022) · doi:10.33612/diss.202010693

Additional file 2 of Imbalanced cortisol concentrations in glycogen storage disease type I: evidence for a possible link between endocrine regulation and metabolic derangement

Rossi, A., Simeoli, C., Salerno, M., Ferrigno, R., Casa, R. D., Colao, A., Strisciuglio, P., Parenti, G., Pivonello, R., & Melis, D. (2020) · Figshare · doi:10.6084/m9.figshare.12153864

Additional file 1 of Imbalanced cortisol concentrations in glycogen storage disease type I: evidence for a possible link between endocrine regulation and metabolic derangement

Rossi, A., Simeoli, C., Salerno, M., Ferrigno, R., Casa, R. D., Colao, A., Strisciuglio, P., Parenti, G., Pivonello, R., & Melis, D. (2020) · Figshare · doi:10.6084/m9.figshare.12153858

Additional file 4 of Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia

Rossi, A., Assunto, A., Rosano, C. L., Tucci, S., Ruoppolo, M., Caterino, M., Pirozzi, F., Strisciuglio, P., Parenti, G., & Melis, D. (2023) · Figshare · doi:10.6084/m9.figshare.23305120

Additional file 1 of Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia

Rossi, A., Assunto, A., Rosano, C. L., Tucci, S., Ruoppolo, M., Caterino, M., Pirozzi, F., Strisciuglio, P., Parenti, G., & Melis, D. (2023) · Figshare · doi:10.6084/m9.figshare.23305111

Additional file 7 of Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia

Rossi, A., Assunto, A., Rosano, C. L., Tucci, S., Ruoppolo, M., Caterino, M., Pirozzi, F., Strisciuglio, P., Parenti, G., & Melis, D. (2023) · Figshare · doi:10.6084/m9.figshare.23305129

Additional file 3 of Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia

Rossi, A., Assunto, A., Rosano, C. L., Tucci, S., Ruoppolo, M., Caterino, M., Pirozzi, F., Strisciuglio, P., Parenti, G., & Melis, D. (2023) · Figshare · doi:10.6084/m9.figshare.23305117

Additional file 2 of Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia

Rossi, A., Assunto, A., Rosano, C. L., Tucci, S., Ruoppolo, M., Caterino, M., Pirozzi, F., Strisciuglio, P., Parenti, G., & Melis, D. (2023) · Figshare · doi:10.6084/m9.figshare.23305114

Additional file 6 of Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia

Rossi, A., Assunto, A., Rosano, C. L., Tucci, S., Ruoppolo, M., Caterino, M., Pirozzi, F., Strisciuglio, P., Parenti, G., & Melis, D. (2023) · Figshare · doi:10.6084/m9.figshare.23305126

Additional file 5 of Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia

Rossi, A., Assunto, A., Rosano, C. L., Tucci, S., Ruoppolo, M., Caterino, M., Pirozzi, F., Strisciuglio, P., Parenti, G., & Melis, D. (2023) · Figshare · doi:10.6084/m9.figshare.23305123

Glycogen Storage Disease Type I Revealed by Major Hypertriglyceridemia: Significance of Clinicobiological Collaboration

Morjan, A. (2026) · European Journal of Medical and Health Sciences · doi:10.34104/ejmhs.026.06590664

Generation of a glycogen storage disease mouse model with fatty liver and its treatment by PPAR-α agonist bezafibrate

Xie, Y., Fu, G., Fan, C., Huang, H., Yan, J., & Jin, L. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1898810

Increased de novo Lipogenesis and Delayed Conversion of Large VLDL into Intermediate Density Lipoprotein Particles Contribute to Hyperlipidemia in Glycogen Storage Disease Type 1a

Bandsma, R., Prinsen, B. H. C. M. T., der Velden, M. G. M. D. S., Rake, J. P., Boer, T. S., Smit, G., Reijngoud, D., & Kuipers, F. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e31816c9013 · Cited by 89 · see citing works

Glycolysis and Lipogenesis in the Livers form Children with Type I of Glycogen Storage Disease

Tada, K., Shibuya, T., & Akabane, J. (1963) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.81.198

A case of glycogen storage disease type 1a mimicking familial chylomicronemia syndrome

Olgaç, A., Okur, İ., Biberoğlu, G., Ezgü, F., & Tümer, L. (2021) · Balkan Journal of Medical Genetics · doi:10.2478/bjmg-2021-0013 · Cited by 1 · see citing works

A new variant of glycogen storage disease type 1: Probably due to a defect in the glucose‐6‐phosphate transport system

Igarashi, Y., Otomo, H., Narisawa, K., & Tada, K. (1979) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01801717 · Cited by 29 · see citing works

The Molecular Basis of Type 1 Glycogen Storage Diseases

CHOU, J. Y. (2001) · Current Molecular Medicine · doi:10.2174/1566524013364112 · Cited by 50 · see citing works